Skip to main content

HEALTH

  • Prevalence of prediabetes, diabetes among adolescents on the rise

    NEW YORK — Being overweight and obesity during adolescence are associated with an increased risk for cardiovascular disease risk factors, especially prediabetes and diabetes, according to researchers.

  • Dr. Reddy's launches heartburn treatment

    HYDERABAD, India — Dr. Reddy's Labs has launched a generic version of a popular over-the-counter drug for treating heartburn, the company said Monday.

    Dr. Reddy's announced the launch of lansoprazole delayed-release capsules in the 15-mg strength in pack sizes of 14, 28 and 42. The drug is a generic version of Novartis Consumer Health's Prevacid 24 HR capsule brand, which had sales of $115 million during the 12-month period ended in March, according to SymphonyIRI InfoScan Reviews.

  • McNeil Consumer recalls one lot of Imodium on wholesale level due to damaged package

    FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Thursday informed its wholesale customers that it is voluntarily recalling one lot of Imodium multi-symptom relief 18 caplets due to a packaging issue that may have impacted a limited number of blister units in this lot.

    The product is being recalled at the wholesale level only, and not from consumers or from store shelves, as there are no safety concerns or adverse events related to the reason for the recall. The lot number (CMF023) for the recalled product can be found on the side of the product box.

  • Perrigo launches store-brand Prevacid 24HR

    ALLEGAN, Mich. — Perrigo on Friday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for lansoprazole capsules in the 15-mg strength. The capsules are a generic equivalent of Novartis' Prevacid 24HR capsules.

    Sales for Prevacid OTC were approximately $220 million, Perrigo reported.


    Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

  • NAD: Dreambrands to moderate supplement claims following advertising review

    NEW YORK — The National Advertising Division on Friday recommended Dreambrands modify or discontinue a wide range of advertising claims for “Add Lib,” a dietary supplement promoted to women for improved mood, energy and sexual desire.

    Claims at issue included:

    • “Add Lib is an all natural supplement for women to feel better physically, mentally and emotionally — a holistic approach to sustain energy and reduce anxiety — so you can fall in love with life again.”;

  • CDC: Chronic disease states less prevalent as education, household income rise

    ATLANTA — People with higher levels of education and higher income have lower rates of many chronic diseases compared with those with less education and lower income levels, according to "Health, United States, 2011" — the government’s annual comprehensive report on Americans’ health released Wednesday.

  • Prestige Brands: Fiscal 2013 focus on driving core OTC growth

    IRVINGTON, N.Y. — Prestige Brands closed out its fiscal 2012 ended March 31 on a high note with $441.1 million in revenues for the year, up 31.1%. And fiscal 2013 is looking promising as the company will have full-year contributions from its 17 acquired over-the-counter brands from GlaxoSmithKline.

  • Prestige Brands highlights new Dramamine for Kids product in fiscal 2012 call

    IRVINGTON, N.Y. — Prestige Brands on Thursday morning announced the launch of Dramamine for Kids, noting that 34% of households (with children between the ages of 2 years and 12 years) have a child with motion sickness. According to the company, it is estimated that one-third of moms currently are using a Dramamine adult formula but would prefer a pediatric product.

X
This ad will auto-close in 10 seconds